Modification of Fe3O4 magnetic nanoparticles with a GRGD peptide
- 27 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Russian Chemical Bulletin
- Vol. 70 (3), 449-456
- https://doi.org/10.1007/s11172-021-3107-5
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- pH-triggered delivery of magnetic nanoparticles depends on tumor volumeNanomedicine: Nanotechnology, Biology and Medicine, 2019
- A T1/T2 dual functional iron oxide MRI contrast agent with super stability and low hypersensitivity benefited by ultrahigh carboxyl group densityJournal of Materials Chemistry B, 2019
- Triggering antitumoural drug release and gene expression by magnetic hyperthermiaAdvanced Drug Delivery Reviews, 2019
- Advanced Smart Nanomaterials with Integrated Logic-Gating and Biocomputing: Dawn of Theranostic NanorobotsChemical Reviews, 2018
- Biomedical nanoparticle carriers with combined thermal and magnetic response: Current preclinical investigationsJournal of Magnetism and Magnetic Materials, 2018
- Next-generation superparamagnetic iron oxide nanoparticles for cancer theranosticsDrug Discovery Today, 2017
- Yolk/shell nanoparticles: classifications, synthesis, properties, and applicationsNanoscale, 2015
- Nanoparticles in magnetic resonance imaging: from simple to dual contrast agentsInternational Journal of Nanomedicine, 2015
- Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application2011
- Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticlesBiomaterials, 2011